Matthew Biegler
Stock Analyst at Oppenheimer
(2.21)
# 1,489
Out of 4,412 analysts
49
Total ratings
36.36%
Success rate
-0.13%
Average return
Main Sectors:
Top Industries:
19 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELTX Elicio Therapeutics | Reiterates: Perform | n/a | $8.99 | - | 1 | Apr 1, 2024 | |
| VOR Vor Biopharma | Reiterates: Outperform | $17 → $15 | $1.69 | +787.57% | 5 | Mar 21, 2024 | |
| ALPN Alpine Immune Sciences | Reiterates: Outperform | $33 → $44 | $64.56 | -31.85% | 1 | Mar 19, 2024 | |
| ORIC ORIC Pharmaceuticals | Maintains: Outperform | $14 → $17 | $8.07 | +110.66% | 2 | Mar 12, 2024 | |
| OLMA Olema Pharmaceuticals | Reiterates: Outperform | $21 | $9.95 | +111.06% | 3 | Mar 12, 2024 | |
| ARVN Arvinas | Reiterates: Outperform | $95 → $80 | $32.37 | +147.14% | 1 | Feb 28, 2024 | |
| FATE Fate Therapeutics | Reiterates: Perform | n/a | $3.80 | - | 3 | Feb 27, 2024 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Perform | n/a | $14.92 | - | 2 | Feb 27, 2024 | |
| BPMC Blueprint Medicines | Upgrades: Outperform | $85 | $93.00 | -8.60% | 4 | Oct 27, 2023 | |
| FULC Fulcrum Therapeutics | Reiterates: Outperform | $16 | $7.14 | +124.09% | 4 | Aug 22, 2023 | |
| APTO Aptose Biosciences | Maintains: Outperform | $50 → $15 | $1.22 | +1,129.51% | 4 | Aug 11, 2023 | |
| IDYA IDEAYA Biosciences | Maintains: Outperform | $30 → $35 | $39.94 | -12.37% | 2 | Aug 11, 2023 | |
| RLAY Relay Therapeutics | Reiterates: Outperform | $33 | $6.37 | +418.05% | 3 | Aug 9, 2023 | |
| ACRV Acrivon Therapeutics | Initiates: Outperform | $25 | $8.46 | +195.51% | 1 | Jun 2, 2023 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Outperform | $50 | $11.06 | +352.08% | 5 | May 26, 2023 | |
| TYRA Tyra Biosciences | Reiterates: Outperform | $25 | $15.67 | +59.54% | 2 | May 8, 2023 | |
| NKTX Nkarta | Downgrades: Perform | n/a | $6.87 | - | 3 | Dec 22, 2022 | |
| CELU Celularity | Downgrades: Perform | n/a | $3.02 | - | 2 | Dec 22, 2022 | |
| PRTG Portage Biotech | Maintains: Outperform | $26 → $18 | $0.26 | +6,958.82% | 1 | Nov 30, 2022 |
Elicio Therapeutics
Apr 1, 2024
Reiterates: Perform
Price Target: n/a
Current: $8.99
Upside: -
Vor Biopharma
Mar 21, 2024
Reiterates: Outperform
Price Target: $17 → $15
Current: $1.69
Upside: +787.57%
Alpine Immune Sciences
Mar 19, 2024
Reiterates: Outperform
Price Target: $33 → $44
Current: $64.56
Upside: -31.85%
ORIC Pharmaceuticals
Mar 12, 2024
Maintains: Outperform
Price Target: $14 → $17
Current: $8.07
Upside: +110.66%
Olema Pharmaceuticals
Mar 12, 2024
Reiterates: Outperform
Price Target: $21
Current: $9.95
Upside: +111.06%
Arvinas
Feb 28, 2024
Reiterates: Outperform
Price Target: $95 → $80
Current: $32.37
Upside: +147.14%
Fate Therapeutics
Feb 27, 2024
Reiterates: Perform
Price Target: n/a
Current: $3.80
Upside: -
Day One Biopharmaceuticals
Feb 27, 2024
Reiterates: Perform
Price Target: n/a
Current: $14.92
Upside: -
Blueprint Medicines
Oct 27, 2023
Upgrades: Outperform
Price Target: $85
Current: $93.00
Upside: -8.60%
Fulcrum Therapeutics
Aug 22, 2023
Reiterates: Outperform
Price Target: $16
Current: $7.14
Upside: +124.09%
Aptose Biosciences
Aug 11, 2023
Maintains: Outperform
Price Target: $50 → $15
Current: $1.22
Upside: +1,129.51%
IDEAYA Biosciences
Aug 11, 2023
Maintains: Outperform
Price Target: $30 → $35
Current: $39.94
Upside: -12.37%
Relay Therapeutics
Aug 9, 2023
Reiterates: Outperform
Price Target: $33
Current: $6.37
Upside: +418.05%
Acrivon Therapeutics
Jun 2, 2023
Initiates: Outperform
Price Target: $25
Current: $8.46
Upside: +195.51%
Zentalis Pharmaceuticals
May 26, 2023
Reiterates: Outperform
Price Target: $50
Current: $11.06
Upside: +352.08%
Tyra Biosciences
May 8, 2023
Reiterates: Outperform
Price Target: $25
Current: $15.67
Upside: +59.54%
Nkarta
Dec 22, 2022
Downgrades: Perform
Price Target: n/a
Current: $6.87
Upside: -
Celularity
Dec 22, 2022
Downgrades: Perform
Price Target: n/a
Current: $3.02
Upside: -
Portage Biotech
Nov 30, 2022
Maintains: Outperform
Price Target: $26 → $18
Current: $0.26
Upside: +6,958.82%